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athematical modeling is required for understanding
the complex behavior of large signal transduction
networks. Previous attempts to model signal trans-
duction pathways were often limited to small systems or
based on qualitative data only. Here, we developed a
mathematical modeling framework for understanding the
complex signaling behavior of CD95(APO-1/Fas)-mediated
apoptosis. Defects in the regulation of apoptosis result in
serious diseases such as cancer, autoimmunity, and neuro-
degeneration. During the last decade many of the molecular
mechanisms of apoptosis signaling have been examined
M
 
and elucidated. A systemic understanding of apoptosis is,
however, still missing. To address the complexity of apop-
totic signaling we subdivided this system into subsystems
of different information qualities. A new approach for
sensitivity analysis within the mathematical model was key
for the identiﬁcation of critical system parameters and two
essential system properties: modularity and robustness.
Our model describes the regulation of apoptosis on a systems
level and resolves the important question of a threshold
mechanism for the regulation of apoptosis.
 
Introduction
 
Apoptosis is one of the most complex signaling pathways
(Gilman et al., 2002) and an essential property of all higher
organisms. Defects in apoptosis result in a number of serious
diseases such as cancer, autoimmunity, and neurodegeneration
(Krammer, 2000; Peter and Krammer, 2003). To develop
efficient therapies, fundamental questions about molecular
mechanisms and regulation of apoptosis remain to be answered.
Apoptosis is triggered by a number of factors, including UV
light, 
 
 
 
 radiation, chemotherapeutic drugs, growth factor
withdrawal (“death by neglect”), and signaling from the death
receptors (Ashkenazi and Dixit, 1999; Nagata, 1999). Apop-
tosis pathways can generally be divided into signaling via the
death receptors (extrinsic pathway) or the mitochondria
(intrinsic pathway). Both pathways imply caspases as effector
molecules (Thornberry and Lazebnik, 1998; Salvesen, 2002).
CD95-induced apoptosis is one of the best-studied apop-
tosis pathways. CD95 is a member of the death receptor
family, a subfamily of the TNF-R superfamily. Cross-linking
of CD95 either with its natural ligand, CD95L, or with
agonistic antibodies, such as anti–APO-1, induces apoptosis
in sensitive cells. Upon CD95 stimulation the death-inducing
signaling complex (DISC) is formed. The DISC consists of
oligomerized CD95, the death domain (DD) containing
adaptor molecule FADD, procaspase-8, procaspase-10, and
c-FLIP (c-FLIP occurs in two splice forms, c-FLIP
 
L
 
 and
c-FLIP
 
S
 
). As a result of CD95 DISC formation procaspase-8
is autocatalytically cleaved at the DISC resulting in the for-
mation of active caspase-8 starting the apoptotic signaling
cascade (Lavrik et al., 2003). Two CD95-signaling pathways
were established. Type I cells are characterized by intensive
DISC formation and mitochondria-independent caspase-3
activation. In type II cells the formation of the DISC complex
is reduced and the activation of caspase-3 occurs down-
stream of the mitochondria: the active form of caspase-8
cleaves Bid, followed by tBid translocation to mitochondria
resulting in the release of cytochrome C, apoptosome forma-
tion, and the activation of caspase-9, which then activates
caspase-3 triggering the subsequent apoptotic events.
Despite the ever-increasing number of studies on CD95-
induced apoptosis, a systemic understanding of this complex
signaling pathway is still missing. It is well accepted that the
 
M. Bentele and I. Lavrik contributed equally to this work.
The online version of this article contains supplemental material.
Address correspondence to R. Eils, DKFZ, Division Theoretical Bioinfor-
matics, Im Neuenheimer Feld 580, Heidelberg 69120, Germany. Tel.:
(49) 6221-423600; Fax: (49) 6221-423610; email: r.eils@dkfz.de
Key words: mathematical modeling; CD95-induced apoptosis; sensitivity
analysis; parameter estimation; threshold mechanism
 
Abbreviations used in this paper: CHX, cyclohexamide; DD, death domain;
DISC, death-inducing signaling complex. 
840 The Journal of Cell Biology 
 
|
 
 
 
Volume 166, Number 6, 2004
 
system response to, for example, biochemical intervention of
the apoptotic signaling pathway is regulated by many differ-
ent factors at a time. The question of a threshold for induc-
tion of apoptosis plays a central role in our understanding of
the sensitivity and resistance of cells toward various chemo-
therapeutic agents.
There is no experimental approach available at present
that allows monitoring of immediate and long-term changes
of all affected molecules in the course of apoptosis. Here, a
mathematical model of apoptosis integrating the presently
distributed and heterogeneous knowledge about apoptosis in
an integrated model would be of great benefit, since it allows
the identification of most sensitive signaling molecules and
predictions on the systemic behavior of apoptotic signaling,
e.g., upon stimulation by different molecules or through in-
teraction of chemotherapeutics. Besides the formulation of
biological hypotheses, a mathematical model would be also
very beneficial for the design of new experiments by suggest-
ing the most promising next experiments to experimentally
address a specific biological question.
Mathematical modeling has a long tradition in biomedi-
cal applications and bioengineering. For the analysis and a
better understanding of metabolic networks, kinetic path-
way models were constructed using a diversity of mathe-
matical and computational methods (Kell and Westerhoff,
1986; Heinrich and Schuster, 1996; Schilling et al., 1999).
This development ranges from the examination of steady-
states and flux modes to a large variety of control theories.
More recently, theoretical models for describing the com-
plex signaling behavior on system levels have been devel-
oped (Lauffenburger, 2000; Csete and Doyle, 2002; Ki-
tano, 2002). Models of signal transduction networks are
either based on discrete models describing signaling as in-
formation processing (Regev et al., 2001) or on continuous
models where the information flux is modeled by a bio-
chemical reaction network. In the latter case, the reaction
network is translated into a system of ordinary differential
equations (Sauro and Fell, 1991; Mendes, 1997; Bhalla and
Iyengar, 1999).
A robust and reliable mathematical simulation of signal
transduction networks requires quantitative information on
reaction rates and molecular concentrations. For most reac-
tions and molecules, these parameters are not directly acces-
sible in vivo. Existing signal transduction data usually refers
to different experimental settings, cell types and states of
cells and can therefore practically not be used for quantita-
tive models of signal transduction. Further, signaling pro-
cesses are described on different levels of information quality
ranging from mechanistically well-understood interactions
to purely qualitative processes like activation or inhibition.
Accordingly, mathematical simulations of signal transduc-
tion networks typically address well-investigated pathways
where most biochemical mechanisms are well understood
(Kholodenko et al., 1999; Schoeberl et al., 2002). In a re-
cent data-based study on the JAK-STAT pathway, Swameye
et al. (2003) reliably measured data and parameter estima-
tion (Mendes and Kell, 1998), i.e., the determination of val-
ues of unknown model parameters to provide an optimal fit
between the simulation and experimental data, and these
have been suggested as key components for model identifica-
tion (Deuflhard, 1983) and reliable quantitative simula-
tions. However, the number of assessable parameters and
therefore the maximum size of the model have been very
limited due to the large amount of experimental data re-
quired for high-dimensional parameter estimation problems
and the curse of dimensionality. Curse of dimensionality re-
fers to the problem that the space of possible sets of parame-
ter values grows exponentially with the number of unknown
parameters severely impairing the search for the globally op-
timal parameter values. In a first attempt to theoretically de-
scribe apoptotic signaling a mathematical model including
more than 20 reactions was proposed (Fussenegger et al.,
2000). However, this model was based on ad hoc fixed pa-
rameters and thus its potential for understanding the regula-
tion of apoptosis remains very limited.
Here, we will present an approach overcoming the present
obstacles in large-scale modeling of signal transduction net-
works. Our approach integrates information on various dif-
ferent levels in a unified form. We will derive a data-based
model of CD95-induced apoptosis with parameters esti-
mated on the basis of quantitative experimental data. Our
numerical simulations thus allow the prediction of the sys-
temic behavior of CD95-induced apoptosis including a
mechanism for the regulation of apoptosis, which will be
demonstrated in detail here for the first time. By validating
our model hypotheses experimentally, we will show how
through iteration of theoretical modeling and experiments
we will gain a new insights into the regulation of apoptosis
that would have not been achieved with either the theoreti-
cal or experimental part missing.
 
Results
 
Structured information model of CD95-induced apoptosis
 
We reconstructed the network topology of CD95-induced
apoptosis by critically searching databases (e.g., Schacherer et
al., 2001; http://www.biobase.de/) and the literature. Mole-
cules and reactions directly or indirectly interacting with the
known components of this pathway were incorporated lead-
ing to a model with 
 
 
 
70 molecules, 80 reactions, and more
than 120 unknown parameters (data not shown). This com-
plexity cannot be matched by experimental data at present.
To reduce the complexity of the model without sacrific-
ing essential components of the network, we incorporated
subunits of different information qualities: reactions with
well-understood biochemical mechanisms, e.g., those of the
DISC-system or of the caspases, were modeled mechanisti-
cally. For all other interactions, “black boxes” were intro-
duced, defined by their experimentally observed input–out-
put behavior (see Online supplemental material). Notably,
these black boxes do not assume knowledge of the exact un-
derlying mechanisms. Subsystems (boxes) were identified ac-
cording to the following criteria: the input–output behavior
should be measurable, the number of input–output variables
should be low, subsystems should represent real functional
systems (e.g., mitochondria) and the information within one
subsystem should be on the same level. The decomposition
of the complete system into subsystems is an iterative and
adaptive process. Based on new experimental data, a sub-
system might be split into further subsystems. 
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A great advantage of the so-obtained “structured informa-
tion model” is that it combines heterogeneous information
in one model instead of dealing with isolated models. The
resulting model of CD95-induced apoptosis consists of 41
molecules (or complexes), 32 reactions, and 2 black boxes
(Fig. 1). However, this simplified model still contains more
than 50 missing parameters and requires further reduction
of complexity to allow robust parameter estimation (see On-
line supplemental material) given the limited number of
data points.
 
Sensitivity analysis reveals intrinsic system behaviors 
and leads to reduction of system complexity
 
For reduction of complexity, we identified the most critical
system parameters by sensitivity analysis. Sensitivities de-
scribe the relative changes of molecule concentrations (and
therefore of the system behavior) as a result of changes of the
parameters. Considering, in general, sensitivities can be de-
termined for specific sets of parameters only (local sensitivity
analysis), the usefulness of sensitivity analysis is limited if
most parameters are unknown at first. In a virtual experi-
ment, we therefore determined sensitivities for a large num-
ber of randomly chosen points in parameter space within
specified ranges, covering more than three orders of magni-
tude (see Materials and methods). Surprisingly, the distribu-
tion of most sensitivities showed distinct and narrow peaks
(Fig. 2) indicating that most sensitivities of the system are
highly robust to large variations in parameter values.
The sensitivity analyses led us to a further inherent system
property, the modularity of the apoptotic signaling pathway.
Apparently, clusters can be identified that contain a subset
of molecules whose concentrations depend on a subset of pa-
rameters only (Fig. 2 and Fig. S2). In addition to these pa-
rameters that can be efficiently estimated locally there are
global parameters belonging to more than one cluster. To
address the problem of global parameters we designed a hier-
archical approach where parameter estimation is performed
on two levels. On the upper level, global parameters are esti-
mated by optimising all clusters: for each cluster, parameter
estimation is recursively called at the lower level. The low-
level parameter estimation depends on the global parameter
values proposed by the algorithm on the upper level, but is
independent of local parameters within other clusters (see
Online supplemental material). In a second step, we intro-
duced a sensitivity control within the parameter estimation
algorithm, which calculates the local sensitivities after each
step in parameter space to determine a subset of parameters
relevant for the next estimation step (see Online supplemen-
tal material). As a result of the sensitivity control within the
parameter estimation the value for the objective function re-
lated to the optimal fit could be decreased by one to two or-
ders of magnitude. The system dimensionality was reduced
from 58 unknown parameters to 18.
 
Experimental design for probing regulatory 
mechanisms of CD95-induced apoptosis
 
Based on the results of the sensitivity analysis we designed a
set of experiments to measure time series of concentrations
of 15 different molecules after activation of CD95 receptors
(Fig. 1). For our experiments, we chose the human B lym-
phoblastoid cell line SKW 6.4, classified previously as type I
cells by their high amount of DISC formation. These cells
are highly sensitive to CD95-mediated apoptosis. Cells were
stimulated with different concentrations of agonistic anti–
APO-1 antibody or LZ-CD95L for various periods of time
(from 5 min to 4 d). Each sample was evaluated by three in-
dependent approaches. Cell death was determined by flow
cytometry, caspase activity was measured by fluorometric ac-
Figure 1. Structured information model 
of CD95-induced apoptosis. In the 
mechanistic part (DISC, Caspases, IAP), 
interactions are modeled as elementary 
reactions including competitive inhibitions 
and enzymatic reactions. Receptors are 
activated by ligands initiating the DISC 
formation. After binding to the DISC 
binding site (DISCbs), procaspase-8 is 
cleaved (initiator caspase), followed by 
the activation of executioner caspases 
(-3, -6, -7). PARP cleavage was chosen 
as experimental end-point of the pathway. 
The mitochondria and the degradation 
process, which influences all molecules, 
are modeled as black boxes defined by 
their input-output behavior (see Online 
supplemental material). Each reaction 
contains one or more unknown parame-
ters. Experimental time series were 
measured for all molecules framed in red. 
For details on reactions and parameters 
see Table SI. Note that due to model 
simplifications some molecule species 
are replaced by virtual substitutes (e.g., 
XIAP and IAP1/2→”IAP”). 
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tivity, and the change of concentration of major apoptotic
molecules was evaluated by Western blot. For all measure-
ments, standardization of experiments was crucial.
To standardize the assays, SKW 6.4 cells were taken from
the logarithmic growth phase. To ensure the linear relation
between the antigen and the strength of the signal in the
Western blot, serial dilutions of recombinant proteins or cell
lysates were probed with various antibodies. Quantification
of chemiluminescence showed good linearity in proportion
to the amount of an antigen (Fig. S3). Thus, the following
Western blot experiments were performed using the same
concentrations of the antibodies.
In a first set of experiments, time series were measured for
a “fast” activation scenario with an oversaturated ligand
concentration corresponding to more than one ligand per
CD95 receptor. Oversaturation was achieved by 5 
 
 
 
g/ml
anti–APO-1 corresponding to a ligand–receptor ratio of
 
 
 
5:1. The ratio was determined under the assumption that
there are 
 
 
 
40,000 CD95 receptors per cell. This number
was estimated from measurements by flow cytometry (data
not shown).
A good fit between model simulation and experimental
data could be achieved reproducing the fast cleavage of pro-
caspase 8 into its active form, followed by activation of the
executioner caspases and cleavage of Bid and PARP (Fig. 3
and Fig. 4, A–C). We conclude that the mathematical
model is well suited to quantitatively describe the activation
of CD95-induced apoptosis. However, the model is still un-
derdetermined, i.e., different model parameter settings are
able to match the same experimental data. Accordingly, gen-
eralization of the model for biological predictions is likely
limited. Therefore, we decided to gain more information
about the system by measuring different activation scenarios
with lower initial ligand concentrations and to base the pa-
rameter estimation on these multiple conditions (Fig. 5 B
and Fig. 6). Thus, an integrated model including different
activation scenarios was automatically generated. The inte-
grated model is based on a common set of biochemical pa-
rameters but different initial values of ligand concentration.
It fits several activation scenarios as a result of one combined
parameter estimation step (Fig. 4, A–E).
 
Threshold mechanism for CD95-induced apoptosis: 
model prediction and experimental validation
 
Both the model predictions and the experimental data
show that with decreasing ligand concentrations apoptosis
is slowed down considerably; however, cell death is still
achieved. To address the question whether the apoptotic
process slows down continuously with lower ligand concen-
trations or whether there is a threshold for induction of
apoptosis at a distinct receptor–ligand ratio, we simulated
induction of apoptosis for very low ligand concentrations.
Our model predicts that below a critical concentration cor-
responding to a ligand–receptor ratio of 
 
 
 
1:10
 
2
 
, apoptosis is
completely stopped (Fig. 4, F–H). This prediction was vali-
dated by experiments (Fig. 4, M–O).
It remains puzzling that even for the below-threshold sce-
nario a sufficient number of receptors should be activated to
cleave procaspase-8, thereby triggering all subsequent cas-
pases. In the model, the caspase-8 cleavage capacity at the
DISC is assumed to be proportional to the number of active
CD95 receptors since the DISCs are supposed to remain ac-
tive after cleaving procaspase-8 molecules. Consequently,
the rate of caspase-8 cleavage continuously decreases with a
lower ligand concentration. In an intuitive interpretation,
one would thus assume that even for a very low ligand con-
Figure 2. Sensitivity matrix of parame-
ters and molecules. (A) The sensitivity 
matrix (sij) shows the relative changes 
of the concentrations of molecule i (left 
to right) due to a change of parameter j 
(front to back). The indices refer to Table 
SI. Sensitivities are low in general ( 1) 
indicating high robustness. The sensitivities 
of the executioner caspases (Fig. S1) are 
extremely low indicating the extreme 
robustness of the core functionality of the 
apoptotic system. (B) Sensitivity of sensi-
tivities: each box shows one histogram 
for a specific sensitivity, calculated for 
300,000 randomly chosen points in 
parameter space. X axis: sensitivity; Y axis: 
relative density of occurrence (weighted 
with a Boltzmann-distribution; see 
Online supplemental material). The histo-
grams shown here are representative for 
the complete matrix. They show distinct 
and narrow peaks in most cases. Sensi-
tivities with a clear peak close to zero 
indicate that the respective molecule 
concentration is insensitive to the 
respective parameter (an important 
property for further modularization). 
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Figure 3. Experimental data obtained 
for the fast activation scenario. Anti–
APO-1 antibodies were added to SKW 
6.4 cells in a concentration of 5  g/ml 
and the samples were incubated at 37 C 
for various time points. Unstimulated 
cells were incubated in parallel for the 
same amount of time. (A) The cleavage 
of procaspase-8 was analyzed by Western 
blotting using anti–caspase-8 mono-
clonal antibodies. The positions of 
procaspase-8 (p55/p53) and the respective 
cleavage fragments are indicated. 
Recombinant caspase-8 in serial dilutions 
was loaded on the same Western blot 
for calibration. Above each lane the 
percentage of cell death is presented. 
As a loading control we used anti-actin 
monoclonal antibodies. The caspase-8 
activity was analyzed using a fluoro-
metric activity assay with z-IETD-afc. 
Data are presented from three indepen-
dent experiments. (B) The processing of 
procaspase-2 was analyzed by Western 
blotting using anti–caspase-2 monoclonal 
antibodies. The positions of procaspase-2 
and the respective cleavage fragments 
are indicated. (C and D) The processing 
of procaspases-3 and -7 was analyzed 
by Western blotting with corresponding 
antibodies. (E) Analysis of PARP cleavage 
by Western blotting. 
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Figure 4. Model predictions and experimental validation. (A–E) Parameter estimation on the basis of fast and reduced activation scenarios 
(5  g/ml and 200 ng/ml of anti–APO-1, respectively) led to a good fit between model simulations (SIM, solid lines) and experimental data 
(EXP, dots) for both scenarios. (A) The high ligand concentration leads to an early activation of receptors, followed by fast DISC formation, 
resulting in a high cleavage capacity of procaspase-8 via the intermediate product (p43/p41). (B and C) Early generation of active caspase-8 
is followed by the cleavage of caspase-3, -7, and -2 as well as by cleavage of Bid and PARP. After PARP cleavage, decomposition of cellular 
components starts. (D and E) The model computed for slower activation (200 ng/ml) using the same set of biochemical parameters. Due to 
the smaller percentage of receptors activated by ligands, the capacity of caspase-8 cleavage is much lower. However, there is still a cleavage 
of 100% of the executioner caspases and PARP resulting in apoptosis. (F–I) To test the hypothesis of a threshold behavior of CD95-induced 
apoptosis, activation was simulated for even lower ligand concentrations (10 and 1 ng/ml, respectively) using the estimated parameter set 
previously. Note that for the intermediate activation strength of 10 ng/ml we applied stochastic instead of deterministic simulations (for details 
see Online supplemental material and Bentele and Eils, 2004). As expected, caspase-8 cleavage is slowing down (F). However, for 1 ng/ml 
(G) the death process was completely stopped. Active caspase-8 and all the subsequent caspases could not be generated in a number sufficiently 
high to trigger apoptosis (H, log-scale). According to the model, c-FLIP is blocking the low number of active DISCs (see red and green curve 
in I) before caspase-8 can be generated in a sufficiently high amount. Without c-FLIP, the number of active DISCs and therefore their cleavage 
capacity would be significantly higher (dotted line in I). (J and K) The simulation for c-FLIP reduced by 75% shows a slow and steady cleavage 
of procaspase-8 until caspase-3 is generated in a number sufficiently high to trigger the feedback loop via caspase-6, accelerating the activation 
of caspase-8 and resulting in apoptosis after a delay of many hours (compare H and K on a log-scale). (L) A similar effect could be simulated 
for IAP reduced by 75% showing the importance of this inhibitor in case of slow activations (compare G and L). (M) Caspase-8 activity: the 
model predictions for slow activation scenarios (ligand concentrations between 100 and 1 ng/ml) were confirmed by experiments. In particular, 
the predicted delay of caspase activation was quantitatively validated. In the 10 ng/ml activation scenario, a significant increase of active 
caspase-8 was observed after more than 4 h (data not shown) as predicted in panel F, whereas no increase occurred for 1 ng/ml. (N) The death 
rates are in a good agreement with the model, which predicts triggering of the death process for the scenarios of 10 ng/ml and above. However, 
the measured death rate for 10 ng/ml was below 100%. Note that these rates were measured for a population of many cells whereas deter-
ministic simulations address single cells (or a population of many cells with exactly the same parameters and initial conditions, respectively). 
Variability of parameters and of numbers of ligands as well as intrinsic stochastic effects due to low particle numbers might account for 
fluctuations in scenarios close to the activation threshold. Accordingly, simulations for slightly different parameter values in this scenario 
showed that the time-point of apoptosis is highly variable or apoptosis does not take place at all (data not shown) resulting in a death rate 
of below 100% for the cell population. (O) In the subthreshold scenario, only an extremely low increase of active caspase-8 and no increase 
of active caspase-3 was measured (y axis shows the -fold increase). For higher ligand concentrations, the low caspase activity is due to prior 
degradation. Y axis for A–L: arbitrary units (except for A and D where the [pro-]caspase concentrations are directly comparable and thus given 
in relative units). The standard deviation of experimental data was 20% on average. 
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centration apoptosis should not be stopped entirely, but
would only be delayed. We addressed the apparent contra-
diction between model prediction and intuitive consider-
ations by elucidating the exact mechanism of this threshold
behavior and by revealing the responsible molecules and mo-
lecular interactions in our model.
Binding of the short and the long variants of c-FLIP to
the DISC competes with activation of caspase-8 (Krueger
et al., 2001). According to the parameter estimation, there
are many more CD95 receptors and procaspase-8 mole-
cules than c-FLIP molecules. Note, that we consider this
estimate very reliable since the quality of our parameter fit
was highly sensitive with respect to different models of
c-FLIP interactions (Fig. S4) and different parameter settings
in this part of the model. The cleavage rate of procaspase-8
is dependent on the number of active receptors. Whenever
c-FLIP binds to a DISC, the respective binding site is
blocked. The simulation of a scenario with subthreshold
concentrations of activating ligand shows a steady decrease
of active DISCs until all of them are blocked by c-FLIP
(Fig. 4 I).
As a consequence, the simulation shows a limited genera-
tion of the intermediate caspase-8 cleavage product p43/
p41, mainly due to the presence of c-FLIP
 
L
 
 (Fig. 4, G and
H), but no significant generation of active caspase-8 as a re-
sult of the early and complete DISC blockage. In contrast,
the simulation for a ligand–receptor ratio above the thresh-
old shows an entirely different behavior: due to the higher
number of active receptors, the amount of c-FLIP is not suf-
ficient to block all DISCs before active caspase-8 can be gen-
erated in a quantity that is sufficient to trigger apoptosis.
Thus, the c-FLIP mechanism identified in the model can be
considered a switch, which blocks the activation of caspase-8
for signals (ligand concentrations) below a critical quantity
and passes on the activation signal above this level. As a con-
sequence, the threshold is highly sensitive to the concentra-
tion of c-FLIP (Fig. 4, J and K).
To confirm the model predictions experimentally we down-
regulated FLIP level in SKW6.4 cells using translation inhibi-
tor cyclohexamide (CHX; Fig. 7). The addition of CHX
decreased c-FLIP level up to 70% and did not change the
amount of procaspase-8 (Fig. 7). Down-regulation of c-FLIP
Figure 5. Framework for modeling and 
simulation of large signal transduction 
networks. (A) Before parameter estimation, 
sensitivities are determined for randomly 
chosen points in parameter space. All 
sensitivities with a distinct peak close to 
zero are considered irrelevant (compare 
Fig. 2). In the next step (clustering), irrele-
vant sensitivities are removed (white 
squares), and the matrix is rearranged in 
a way that provides independent clusters 
(see Online supplemental material). On 
this basis, the parameter estimation is 
performed for each cluster independently 
by minimization of the respective objec-
tive function. In case of global parameters, 
the parameter estimation for the single 
clusters is recursively called within the 
parameter estimation for the global pa-
rameters. The right-hand side displays the 
core part of the computational system. 
Whenever sensitivity analysis is applied 
or the objective function has to be deter-
mined for parameter estimation, the simu-
lation is started with a certain parameter 
set. The simulation is based on the bio-
chemical reaction equations and on the 
definition of the black boxes, which are 
automatically translated into a system of 
differential equations (model generation). 
The result of the simulation is used to eval-
uate sensitivities and the objective function 
by comparing model predictions with 
experimental data. (B) Additional informa-
tion can be gained by measuring the 
dynamic system behavior under different 
initial conditions. The unknown parame-
ters are estimated for all different initial 
conditions at once. These scenarios are 
simulated in parallel. The maximum 
likelihood estimation minimizes the 
sum of the respective objective functions 
depending on the corresponding experi-
mental datasets. 
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under these conditions resulted in cell death already occurring
upon a ligand concentration of only 1 ng/ml. This concentra-
tion was shown both experimentally and theoretically to be be-
low the critical value required for apoptosis without CHX.
These experiments show the important role of c-FLIP concen-
tration in the regulation of CD95-induced apoptosis and
clearly confirm our model predictions (Fig. 4, J and K).
 
Model-based hypothesis checking of competing 
threshold mechanisms
 
We then used our modeling framework to address the dis-
cussion about threshold mechanisms involving downstream
inhibitors like IAP or XIAP (Silke et al., 2001; Salvesen and
Duckett, 2002). Especially in the case of a low caspase-8 ac-
tivity, IAP concentration is highly relevant because it di-
rectly influences the critical caspase-8 activity, above which
the feedback amplification loop caspase-8
 
→
 
caspase-3
 
→
 
cas-
pase-6
 
→
 
caspase-8, is triggered. The triggering of this loop is
highly sensitive with respect to the concentration of active
caspase-8. Once the loop is triggered via caspase-3 cleaved
by caspase-8, the death process cannot be stopped anymore
(point of no return).
Thus, we considered IAP to induce a similar threshold
mechanism by efficiently blocking caspase-3 up to a critical
quantity only. Above this quantity, we predict that caspase-3
starts the irreversible death process by triggering the amplifi-
cation loop. Consequently, for low IAP concentrations, this
loop becomes active for decreased concentrations of active
caspase-8 resulting in a complete cell death (Fig. 4 L),
whereas high IAP concentrations either inhibit or delay this
event for many hours or days. Thus, IAP also influences the
threshold of ligand concentration, however, IAP alone is not
sufficient to inhibit apoptosis in the absence of c-FLIP, since
it can block signaling only in case of low caspase-8 activities.
Therefore, the influence of IAP is low for ligand concentra-
tions significantly above the threshold. Consequently, our
model suggests that the main threshold of CD95-induced
apoptosis is determined upstream in the DISC by prevent-
ing a steady increase of active caspase-8 resulting in the trig-
gering of the amplification loop for subthreshold ligand con-
centrations.
The ratio between active receptors and c-FLIP as well as
the ratio between binding rates of c-FLIP to DISC and of
procaspase-8 to DISC, respectively, are highly relevant pa-
rameters for this threshold (Fig. 4, J and K). Another impor-
tant model prediction addresses the system behavior above
the threshold, where the combination of the c-FLIP mecha-
nism with the amplification loop does not lead to a steadily
decreased caspase cleavage rate upon a decreased ligand con-
centration. Instead, the caspase cleavage, the amplification
loop and the subsequent death process are supposed to be de-
layed, but still complete (Fig. 4, M and N), until it is entirely
Figure 6. Activation with lower ligand 
concentration. Anti–APO-1 antibodies 
were added to SKW 6.4 cells in a con-
centration of 200 ng/ml and the samples 
were incubated at 37 C for various time 
points. (A) The cleavage of procaspase-8 
was analyzed by Western blotting using 
anti–caspase-8 monoclonal antibodies. 
The positions of procaspase-8 (p55/p53) 
and the respective cleavage fragments 
are indicated. (B) The cleavage of pro-
caspase-9 was analyzed by Western 
blotting using anti–caspase-9 monoclonal 
antibodies. (C) The processing of pro-
caspase-2 was analyzed by Western 
blotting. (D) Analysis of PARP cleavage. 
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stopped below the threshold. Thus, low ligand concentra-
tions above the threshold result in no observable system
changes (e.g., caspase activation) for up to many hours until
the caspases abruptly become active and the complete death
process starts without any external stimulation of the system.
 
Experimental validation of threshold mechanism
 
We experimentally verified the proposed threshold mecha-
nism by testing the model predictions for several scenarios.
The caspase-8 activation was measured for a series of lower
ligand concentrations, quantitatively confirming the pre-
dicted delays, the complete cleavage of procaspase-8 above
and the blockage of the active caspase-8 generation below
the threshold (Fig. 4, M, H, and O). To prove the proposed
mechanism, we systematically scanned the activity of up-
and downstream molecules below the threshold.
The experiments confirmed that a low amount of p43/41
and an extremely low amount of active caspase-8 were gen-
erated below the critical activation threshold as predicted by
the model (Fig. 4 O and H). We did not observe any signif-
icant activity of caspase-3, which would (according to the
simulation) otherwise have triggered the feedback loop (Fig.
4 O). Further, neither PARP cleavage nor cell death (Fig. 8
and Fig. 4 N) was observed. This is a clear indication that
the main signal is stopped upstream at the DISC by c-FLIP,
and that IAP, the second important inhibitor, prevents the
sensitive caspase-3 activity from reaching a significant level
upon low amounts of caspase-8 as predicted by simulation.
 
Discussion
 
Mathematical framework provides basis for modeling 
and simulation of complex biochemical pathways
 
In the present study, we showed that the mathematical model
of CD95-induced apoptosis provides novel insights into im-
portant regulatory mechanisms for induction of apoptosis. We
were able to develop a data-based mathematical model for a
very complex signaling pathway such as programmed cell
death that was thoroughly validated by experiments. The
problem of high number of unknown parameters could be re-
Figure 7. Summary sentence to be provided. (A) SKW 6.4 cells 
were treated with CHX for 2 h. Thereafter, cells were stimulated with 
indicated concentrations of anti–APO-1 antibodies for one day. Cell 
death was determined using FACS analysis. (B) Amounts c-FLIP and 
procaspases-8, -3, and -9 before and after CHX treatment were ana-
lyzed by immunoblotting. (C) SKW 6.4 cells were treated with 
CHX and anti–APO-1 antibodies as in A. The cleavage of procaspase-8 
was analyzed by Western blotting using anti–caspase-8 antibody.
Figure 8. Activation with threshold 
ligand concentration. Anti–APO-1 anti-
bodies were added to SKW 6.4 cells in 
concentrations of 100 and 1 ng/ml, 
respectively, and the samples were incu-
bated at 37 C for 1 d. For 1 ng/ml, neither 
cell death nor any significant caspase-3 
and -8 activities were observed (compare 
Fig. 4). Upon stimulation with 100 ng/ml 
the cells were dead after 1 d and some 
residual caspase-3 and -8 activities were 
monitored. The levels of expression of 
different apoptotic molecules were moni-
tored by Western blot and are presented 
for (A) procaspase-8, (B) procaspase-3, 
(C) procaspase-9, (D) c-Flip, (D) PARP, 
and (E) procaspase-2. 
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solved by incorporating parameter sensitivities into the param-
eter estimation, thus drastically reducing the complexity of the
problem. Two inherent system properties, i.e., modularity and
high robustness (Alon et al., 1999; Carlson and Doyle, 2002)
of parameter sensitivities, which were revealed by our mathe-
matical model, in particular by the new concept of “sensitivity
of sensitivities,” were essential here. Different levels of infor-
mation were incorporated by additionally using black boxes
described by their observed input–output behavior where ex-
act knowledge on biochemical reactions is missing.
The developed framework (Fig. 5 A) provides a general
basis for large-scale modeling and simulation of complex
biochemical networks including signal transduction path-
ways and metabolic networks. The proposed method for au-
tomatic model reduction can be readily applied to other ap-
plications such as modeling of pathways involved in cell
proliferation and differentiation. The widely used approach
of manually simplifying models before parameter fitting is
time-consuming and potentially introduces a user bias into
the model. In contrast, the intrinsic reduction of the model
dimensionality proposed here is systematic and adaptive to
both the original model and the experimental data. Further,
the techniques applied here, like combination of heteroge-
neous information levels or modularization of parameter es-
timation, are based on very general properties of biochemical
networks and are well-adapted to the presently limited avail-
ability of reliable kinetic data.
 
Model-based hypothesis checking for qualitative 
assessment of regulatory mechanism 
for CD95-induced apoptosis
 
An important result of this combined theoretical and ex-
perimental approach was the resolution of the question of a
threshold mechanism for regulation of CD95-mediated
apoptosis. This regulatory mechanism is closely related to
the upstream factor c-FLIP that efficiently blocks caspase-8
activation at the DISC at low ligand concentrations thus
stopping the apoptotic program. To probe this regulatory
mechanism in silico, alternative mechanisms disregarding
the impact of c-FLIP were simulated assuming that pro-
caspase-8 is steadily cleaved at the DISC and the cleavage
rate depends on the number of active receptors. The param-
eters for the cleavage process were chosen as to optimally
fit the original “fast” and “slow” activation experiments.
Simulations for the subthreshold ligand concentration show
a very slow procaspase-8 cleavage that, however, resulted in
a significant caspase-8 activity (Fig. 9 A). This is in clear
contradiction to the experimental data (Fig. 4 O and Fig.
8). The complete scenario was next simulated under the as-
sumption that c-FLIP is not sufficient to block the low
number of DISC binding sites activated as a result of sub-
threshold ligand concentrations: even for such low ligand
concentrations, there would be enough active caspase-8 to
trigger the positive feedback loop, followed by cell death
after a certain delay (Fig. 9 B). This is again in clear con-
tradiction to our experiments, where apoptosis was never
observed at subthreshold ligand concentrations even after
a period of several days (Fig. 4, M and N and data not
shown).
 
Biological relevance of mathematical modeling 
of CD95-induced apoptosis
 
The established loop between model and experiment was an
essential component of this study. Outcomes of experiments
performed for different scenarios and different molecules are
used to verify, to refine, and to adapt the theoretical model,
Figure 9. Down-regulation of c-FLIP results in abolishing the threshold of CD95-induced apoptosis. (A) Virtual experiment for a ligand 
concentration of 1 ng under the assumption that c-FLIP is not blocking the DISCs in an early stage, resulting in a steady caspase-8 cleavage. 
The amplification loop is not considered for 1 ng to show the caspase-8 cleavage contribution of the DISCs only. For comparison, the active 
caspase-8 concentrations for 200 ng and 5  g are given (corresponding to Fig. 4, A and D). Thus, even for the low ligand concentration of 1 
ng, caspase-8 activity would reach a level in the same range as in case of high ligand concentrations (even though delayed). The relative units 
refer to the initial concentration of procaspase-8. (B) Complete scenario with amplification loop, simulated under the assumption that c-FLIP 
does not block the DISCs for 1 ng: the steady increase of active caspase-8 would trigger the complete death process. For comparison, the 
200-ng scenario is plotted (corresponding to Fig. 4 D). Assuming that c-FLIP does not effectively block the DISCs for extremely low ligand 
concentrations, we expect a similar process as triggered by much higher ligand concentrations. 
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which in return was used for experimental planning. Nota-
bly, it would not have been possible to reveal the detailed
mechanism for a threshold behavior of CD95-induced
apoptosis with either the mathematical or experimental part
missing. In this sense, mathematical modeling in the context
of programmed cell death has already proven to be an indis-
pensable part of biological knowledge discovery.
The developed mathematical framework now enables us
to simulate the mechanism of CD95-induced apoptosis un-
der different conditions (e.g., for different expressions of
c-FLIP
 
L
 
, c-FLIP
 
S
 
, or FADD), thereby predicting a higher or
lower resistance to apoptosis. Abnormal c-FLIP expression
has been identified in various diseases connected with dys-
regulation in CD95 signaling such as multiple sclerosis,
Alzheimer’s disease, diabetes mellitus, rheumatoid arthri-
tis,  Hodgkin’s disease, and different cancers (French and
Tschopp, 1997; Micheau, 2003). It was shown that c-FLIP
 
S
 
has a short half-life and c-FLIP
 
S
 
 might be down-regulated by
inhibitors of protein synthesis resulting in sensitization of
tumors to apoptosis. Our modeling framework is a powerful
tool for predicting potential interaction partners of chemo-
therapeutics in the apoptotic pathway and for studying the
mechanism behind the regulation of apoptosis by drugs in
treatment of cancer and other diseases. This is of utmost
biomedical relevance as there is strong evidence showing a
highly complex and dynamic pattern of multiple resistance
mechanisms in particular after challenging tumor cells by
chemotherapeutic drugs. The challenge will be even more
increasing, once the in vivo situation of resistance mecha-
nisms is attempted to be functionally understood (Trauzold
et al., 2003).
 
Impact of mathematical modeling for deciphering 
regulatory mechanisms of signal transduction networks
 
One of the most important roles of mathematical modeling
in this study was related to experimental design and hy-
pothesis generation. Our model predicted a delay of cell
death with decreasing stimulation strength of CD95-induced
apoptosis, which surprisingly resulted in a complete change
of system behavior, i.e., the complete stop of the cell death
program, at very low ligand concentrations. Although our
model is not able to predict precisely at which concentration
level this phase shift occurs for a single cell, the model de-
fines an upper threshold (beyond which all cells dies) and a
lower threshold (beyond which no cells die) for CD95-
induced apoptosis. Between these two threshold values, the
model becomes very instable likely reflecting the stochastic
behavior of the death program in this critical activation
range. The quantitative predictions by the model were used
for designing experiments using ligand concentration for
stimulation of apoptosis exactly in this predicted critical
range.
One might argue that the hypothesis of a complete stop of
apoptosis at low ligand concentration could have been for-
mulated without the help of mathematical modeling. How-
ever, even after experimental observation of the threshold
behavior its mechanistic explanation would have been sub-
ject to intuitive interpretations likely accompanied by many
more experiments to further pinpoint potentially responsible
regulatory mechanisms.
Evidently, mathematical modeling and numerical simula-
tions are highly suited to probe different scenarios and hy-
potheses and to come up with detailed description and
model-based proofs for novel regulatory mechanism. Nota-
bly, in contrast to intuitive interpretations that are usually
subject of intense debate in the research community, predic-
tions based on established mathematical model are unequiv-
ocal and reproducible. It can be well expected that through
experimental design and model-based hypothesis checking
mathematical modeling will play an instrumental role in fu-
ture studies on complex signaling pathways by providing for
a more efficient and more profound biomedical research.
The modular and hierarchical structure of our framework
provides a high degree of flexibility for future model exten-
sions in various ways, either by adding additional pathways
and systems like proliferation or gene expression, or by add-
ing more detailed biochemical mechanisms with more infor-
mation becoming available. A further challenge will be to
describe differences between type I/II cells and to under-
stand different sensitivities to various drugs interacting with
the apoptotic pathway. This work is presently underway in
our laboratories.
 
Materials and methods
 
Structured information model
 
Mechanistic part. 
 
For the mathematical description of the mechanistic part,
interactions were modeled based on biochemical reaction equations. The
state of a cell (or of a cell compartment) is described by the concentration
of all relevant signal transduction molecules (c
 
1
 
, c
 
2
 
,…, c
 
m
 
). The reaction
rates are dependent on these concentrations and on biochemical parame-
ters (k
 
1
 
, k
 
2
 
,…, k
 
n
 
) like binding constants. To describe the temporal behav-
ior, a system of ordinary differential equations is automatically generated
as linear combinations of these rates:
 
(1)
 
where dc
 
i
 
/dt represents the concentration change of molecule i, v
 
j
 
 the rate
of reaction j, and 
 
 
 
ij
 
 the stoichiometric matrix linking the reaction rates
with the affected molecules (see equation below). The complete list of all
reactions and parameters is given in Table SI.
 
(2)
 
Starting with a set of initial concentrations, the ordinary differential
equations system was numerically integrated using an adaptive 4th-order
Runge-Kutta (Gear, 1971) solver. Most of the parameters k and initial con-
centrations c
 
i 
 
(
 
t 
 
  
 
0) are unknown and subject to parameter estimation.
 
Black boxes. 
 
All interactions with unknown exact biochemical or bio-
physical mechanism were modeled in functional subunits defined by their
experimentally observed input–output behavior. In contrast to a reaction-
based equation system, functions are introduced that describe the change
of all molecule concentrations (and other values of interest) influenced by
such a subsystem in dependence of all molecules and parameters influenc-
ing the subsystem:
 
(3)
 
: indices of all molecules influenced by the
functional subunit
: indices of all molecules influencing the func-
tional subunit
dci/dt =  vij ∑ vj ck , () ⋅ ,
Ligand + Receptor Ligand:Receptor →
v ⇒ LR kLR [Ligand] [Receptor] ⋅⋅ =
d Ligand [] dt ⁄ v – LR =
d Receptor [] dt ⁄ v – LR =
d Ligand:Receptor [] dt ⁄  vLR =
dc1 dt ⁄ f 1 cm1  ... cmn_in ,  , k , () =
1      11  ..  ,1 n_out {}
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Boundary conditions (e.g., conservation laws) were taken into account. For
concentration changes of molecules influenced by both the black boxes
and the mechanistic part both effects are added.
To mathematically reproduce the behavior of these subunits, simplified
processes were introduced: the degradation is modeled as an exponential
decay function dependent on the executioner caspase activity, a similar
dependency is assumed for PARP cleavage (for details see Table SI). For
cytochrome C release of mitochondria, B-Splines based on experimental
observations (Goldstein et al., 2000) were introduced. They describe a
complete release within 5 min as soon as Bid reaches a certain level in
comparison to Bcl-2/Bcl-XL.
Sensitivity analysis
Sensitivity analysis was applied to analyze the relative changes of concen-
trations ci within the relevant timeframe as a result of relative changes of
the parameters pj:
(4)
In our study, we determined the integral of absolute sensitivities
 from the beginning of activation to the time point of complete
degradation instead of choosing distinct time points for which the sensitiv-
ities are determined. The parameters of our system are biochemical param-
eters like binding constants and the unknown initial molecule concentra-
tions.
In complex systems, sensitivities can mostly be determined for distinct
points in parameter space only (local sensitivity analysis). A global sensi-
tivity analysis is usually impaired by the high dimensionality of the param-
eter space. Here, we apply sensitivity analysis to identify important system
parameters and the intrinsic system behavior, as well as to detect “inde-
pendent” clusters for a more efficient parameter estimation (see Online
supplemental material). These clusters have to be identified before param-
eter estimation.
Therefore, we defined parameter ranges covering more than three or-
ders of magnitude based on typical values taken from literature for each re-
spective parameter type (Michaelis-Menten constants, bimolecular reac-
tion rates, initial concentrations, etc.). We next randomly walked through
the parameter space within these ranges, performing a sensitivity analysis
at each randomly chosen point. This approach is based on the assumption
that biological systems keep their system properties constant although they
are subject to high parameter fluctuations. This expectation was met to a
great extent. The distribution of sensitivities sij for different locations in the
parameter space was plotted as histograms for each sensitivity (Fig. 2 B).
The occurrences were weighted to account for the objective function E
representing the difference between the experimental data and the simula-
tion result for the respective parameter sets. The weighting factor is based
on the Boltzmann-Distribution exp( E/kbT), amplifying the statistical im-
pact of sensitivities for those parameter sets that are more consistent with
the experimental observations and therefore more probable.
Online supplemental material
The online supplemental material contains full information on cell culture
and reagents (section 5) as well as a full description of antibodies and re-
combinant proteins (section 6) used in this study. Details on model defini-
tion include a description of the reaction system and the definition of black
boxes (section 1). Section 2 explains our approach to cluster-based and
sensitivity-controlled parameter estimation. The method for stochastic sim-
ulation is sketched in section 3. Finally, section 4 contains information on
the implementation of the entire modeling and simulation framework. On-
line supplemental materials are available at http://www.jcb.org/cgi/
content/full/jcb.200404158/DC1.
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